Gapping up
In reaction to strong earnings/guidance:
- HIMX +6.2%, MCHP +4.3%, IDCC +3.9%, ANGO +2.1%
Select semiconductor related names showing strength:
- NXPI +2.3%, AMD +1.8%, ON +1.3%, SMH +1.2%, NVDA +0.8%, AVGO +0.5%
Other news:
- XERS +20% (positive results from in-clinic stage of Phase 2 study of RTU glucagon)
- APA +14.1% (announced a significant oil discovery at the Maka Central-1 well drilled offshore Suriname on Block 58)
- ADMA +9% (enters into a 5-year manufacturing and supply agreement with an undisclosed partner to produce and sell plasma-derived intermediate fractions from ADMA's FDA approved Immune Globulin (IG) manufacturing process)
- CNXN +7.7% (to join S&P SmallCap 600)
- LPG +7.3% (to join S&P SmallCap 600)
- PCRX +4.9% (achieves primary and secondary endpoints for its Phase 4 study of EXPAREL in patients undergoing Cesarean section)
- PDS +1.3% (provides various updastes; debt repayments totaled $205 mln, exceeding its recently increased 2019 annual target of $200 mln)
Analyst comments:
- BECN +4% (initiated with a Buy at Loop Capital)
- MU +3.5% (upgraded to Outperform at Cowen)
- WDC +3.1% (upgraded to Outperform at Cowen)
- FEYE +2.9% (upgraded to Buy from Hold at SunTrust)
- GLUU +2.1% (initiated with a Buy at SunTrust)
- EXAS +1.4% (initiated with a Buy at Citigroup)
- BIOS +1% (initiated with an Outperform at William Blair)
- GH +0.8% (initiated with a Buy at Citigroup)
- CSX +0.7% (upgraded to Positive from Neutral at Susquehanna)
- EOG +0.6% (upgraded to Buy from Neutral at BofA/Merrill)